A new trading day began on Friday, with Nuvation Bio Inc (NYSE: NUVB) stock price down -5.78% from the previous day of trading, before settling in for the closing price of $5.02. NUVB’s price has ranged from $1.54 to $5.55 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -49.14%. Meanwhile, its annual earnings per share averaged 71.86%. With a float of $231.89 million, this company’s outstanding shares have now reached $341.76 million.
Nuvation Bio Inc (NUVB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Nuvation Bio Inc is 32.56%, while institutional ownership is 53.46%. The most recent insider transaction that took place on Oct 27 ’25, was worth 502,460. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 100,000 shares at a rate of $5.02, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 27 ’25, when Company’s Officer proposed sale 100,000 for $4.85, making the entire transaction worth $485,000.
Nuvation Bio Inc (NUVB) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.12 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 71.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.79% during the next five years compared to -49.14% drop over the previous five years of trading.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Here are Nuvation Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 60.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
The latest stats from [Nuvation Bio Inc, NUVB] show that its last 5-days average volume of 9.63 million was superior to 5.17 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 59.51%.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 79.35%, which indicates a significant increase from 56.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.46 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.84, while its 200-day Moving Average is $2.61. Now, the first resistance to watch is $5.03. This is followed by the second major resistance level at $5.33. The third major resistance level sits at $5.62. If the price goes on to break the first support level at $4.44, it is likely to go to the next support level at $4.15. Assuming the price breaks the second support level, the third support level stands at $3.85.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
With a market capitalization of 1.63 billion, the company has a total of 342,273K Shares Outstanding. Currently, annual sales are 7,870 K while annual income is -567,940 K. The company’s previous quarter sales were 4,830 K while its latest quarter income was -59,010 K.
